Skip to main content

Department

Toxicology

Preferred Sample Type

Propranolol

Suitable Specimen Types

  • Serum
  • EDTA Plasma
  • Li Hep Plasma
A minimum of 500 µl of plasma/serum is required.

Specimen Transport

First class post

Sample Processing in Laboratory

Place sample in toxicology rack.

Sample Preparation

None required

Turnaround Time

3 days.

Sample Stability

Keep refrigerated. 4 degrees.

Propranolol

General Information

Propranolol (inderal) is a beta-adrenergic blocking agent that has been used clinically since 1965 as an antihypertensive and antiarrhythmic agent. Adult doses are usually 30 - 320 mg daily orally or 1 - 3 mg intravenously.

Propranolol undergoes a complex pattern of biotransformation in man, with production of several active metabolites. 4-hydroxypropranolol has beta-blocking activity comparable with that of propranolol and is present in plasma after oral adminitration of the drug, but has a shorter half life. Norpropranolol and alpha-naphthoxy-2,3,-propyleneglycol (NPG) also have biological activity, but the extent of their contribution to the effects of drug are uncertain.

Adverse reactions to propranolol include nausea, vomiting, lightheadedness, weakness, visual disturbances, hallucinations, disorientation, memory loss, catatonia, bradycardia, hypotension, congestive heart failure and bronchospasm. Fatal bronchospasm may result in asthmatic patients after even a single therapeutic dose. 

Patient Preparation

For TDM, sample should be taken prior to dose. If toxicity is suspected, take sample at earliest opportunity

Notes

Propranolol measured by HPLC-DAD.

Please note this assay is not currently UKAS accredited

Reference Range

Therapeutic range: 0.02 - 0.3 mg/L.  Toxicity associated with concentrations > 1.0 mg/L.  (Schulz et al. Critical Care 2012, 16:R136). 

Specifications

  • EQA Scheme?: Yes
  • EQA Status: LGC QUARTZ, LGC CLIN TOX